Management of type 2 diabetes: simplicity of Trajenta (linagliptin) for a broad range of patients (Promotional content from Boehringer Ingelheim) | GPnotebook TV

This site is intended for UK healthcare professionals

This video presentation has been organised and funded by Boehringer Ingelheim

Management of type 2 diabetes: simplicity of Trajenta (linagliptin) for a broad range of patients (Promotional content from Boehringer Ingelheim)

1 October 2020

Sponsored

Click here to access the Trajenta prescribing information

Adverse events should be reported. Reporting forms and information can be found at www.mhra.gov.uk/yellowcard. Adverse events should also be reported to Boehringer Ingelheim Drug Safety on 0800 328 1627 (freephone).

PC-GB-102797     October 2020

Thanks for your feedback. Please note that by including your email address, you are giving permission for us to contact you by email to help resolve any issues.

We use anonymous cookies to generate usage statistics. Please click here to find out more.